Shree Mahaveer Pharma-Tech And Drugs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 4.50 M
as on 24-10-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.69 Cr
as on 24-10-2024
- Satisfied Charges ₹ 1.00 M
as on 24-10-2024
- Revenue 27.24%
(FY 2023)
- Profit 63.13%
(FY 2023)
- Ebitda 64.92%
(FY 2023)
- Net Worth 6.22%
(FY 2023)
- Total Assets 1.05%
(FY 2023)
About Shree Mahaveer Pharma-Tech And Drugs
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹2.69 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rudra Behera, Rudra Hota, and Prabhasini Sahoo serve as directors at the Company.
- CIN/LLPIN
U51397OR2011PTC013196
- Company No.
013196
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Feb 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Mahaveer Pharma-Tech And Drugs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rudra Behera  | Director | 22-Feb-2011 | Current |
| Rudra Hota | Additional Director | 10-Jan-2024 | Current |
| Prabhasini Sahoo | Director | 28-Mar-2014 | Current |
Financial Performance of Shree Mahaveer Pharma-Tech And Drugs.
Shree Mahaveer Pharma-Tech And Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.24% increase. The company also saw a substantial improvement in profitability, with a 63.13% increase in profit. The company's net worth moved up by a moderate rise of 6.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Mahaveer Pharma-Tech And Drugs?
In 2023, Shree Mahaveer Pharma-Tech And Drugs had a promoter holding of 78.89% and a public holding of 21.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Shree Mahaveer Health And Healing Care Private LimitedActive 9 months 4 days
Rudra Behera and Rudra Hota are mutual person
- Odisha Shrimp Trading & Exports Private LimitedActive 8 years 11 months
Rudra Hota is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 22 Sep 2022 | ₹1.55 M | Open |
Hdfc Bank Limited Creation Date: 15 Jan 2022 | ₹0.70 M | Open |
Others Creation Date: 29 Oct 2020 | ₹3.70 M | Open |
How Many Employees Work at Shree Mahaveer Pharma-Tech And Drugs?
Unlock and access historical data on people associated with Shree Mahaveer Pharma-Tech And Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Mahaveer Pharma-Tech And Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Mahaveer Pharma-Tech And Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
